Overview

U.S. C-arms Market is poised to value over USD 1 billion by 2027 end at a CAGR of over 4.4% during the forecast period 2020 to 2027.

FutureWise Market Research has instantiated a report that provides an intricate analysis of U.S. C-arms Market trend that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the U.S. C-arms Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the U.S. C-arms Market:
• Canon Medical Systems Corporation
• GE Healthcare
• Hitachi Medical Systems
• Hologic Corporation
• Orthoscan Inc.
• Philips Healthcare
• Shimadzu Medical
• Siemens Health
• Toshiba Medical Systems
• Ziehm Imaging
(Note: The list of the major players will be updated with the latest market scenario and trends)

U.S. C-arms Market Segmentation:
By Product Type
• Fixed C-arms
• Mobile C-arms
   o Full-Size C-Arms
   o Mini C-Arms

By Detector
• Flat Panel Detector
• Image Intensifier

By Application
• Orthopedics and Trauma
• Cardiology
• Neurology
• Gastroenterology
• Oncology
• Others

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the U.S. C-arms Market By Product Type, By Detector and By Application.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— US
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customisation offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
  1.1 Objectives of the Study
  1.2 Market Definition
  1.3 Market Scope
      1.3.1 Years Considered for the Study
      1.3.2 Market Covered
  1.4 Currency
  1.5 Limitations
  1.6 Stakeholders

2. Research Methodology
   2.1 Research Data
       2.1.1 Secondary Data
             2.1.1.1 Key Data from Secondary Sources
       2.1.2 Primary Data
             2.1.2.1 Key Data from Primary Sources
   2.2 Market Size Estimation
   2.3 Market Breakdown and Data Triangulation
   2.4 Assumptions for the Study  

3. Executive Summary
  3.1 Market Outlook
  3.2 Segment Outlook
  3.3 Competitive Insights

4. U.S. C-arms Market Variables, Trends & Scope
  4.1. Market Lineage Outlook
  4.2. Penetration and Growth Prospect Mapping
  4.3. Industry Value Chain Analysis
  4.4. Cost Analysis Breakdown
  4.5. Product Overview
  4.6. Regulatory Framework
       4.6.1. Reimbursement Framework
       4.6.2. Standards and Compliances

5. Market Overview
  5.1. Market Dynamics
       5.1.1. Market Driver Analysis
              5.1.1.1. Increasing focus of Companies on Brand Protection
              5.1.1.2. Untapped Opportunities in Emerging Regions
       5.1.2. Market Restraint Analysis
              5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
       5.1.3. Industry Challenges
              5.1.3.1. Presence of Ambiguous Regulatory Framework

6. U.S. C-arms Market Analysis Tools
  6.1. Industry Analysis - Porter’s
       6.1.1. Supplier Power
       6.1.2. Buyer Power
       6.1.3. Substitution Threat
       6.1.4. Threat from New Entrants
       6.1.5. Competitive Rivalry
  6.2. Pestel Analysis
       6.2.1. Political Landscape
       6.2.2. Environmental Landscape
       6.2.3. Social Landscape
       6.2.4. Product Landscape
       6.2.5. Legal Landscape
  6.3. Major Deals And Strategic Alliances Analysis
       6.3.1. Joint Ventures
       6.3.2. Mergers and Acquisitions
       6.3.3. Licensing and Partnership
       6.3.4. Product Collaborations
       6.3.5. Strategic Divestments
  6.4. Market Entry Strategies
  6.5. Case Studies

7. U.S. C-arms Market, By Product Type Historical Analysis and Forecast 2020-2027 (USD Million)
  7.1. Fixed C-arms
  7.2. Mobile C-arms

8. U.S. C-arms Market, by Detector Historical Analysis and Forecast 2020-2027 (USD Million)
  8.1. Flat Panel Detector
  8.2. Image Intensifier

9. U.S. C-arms Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million)
  9.1. Orthopedics and Trauma
  9.2. Cardiology
  9.3. Neurology
  9.4. Gastroenterology
  9.5. Oncology
  9.6. Others

10. Market Share Analysis and Competitive Landscape  
  10.1. US Landscape - Key Players, Revenue and Presence
  10.2. US Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
  10.3. US Emerging Companies
  10.4. US - Market Share Analysis and Key Regional Players
  10.5. US Key Player - Growth Matrix

11. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
   11.1. Canon Medical Systems Corporation
         11.1.1. Company Overview
         11.1.2. Product Portfolio
         11.1.3. SWOT Analysis
         11.1.4. Financial Overview
         11.1.5. Strategic Overview
   11.2. GE Healthcare
         11.2.1. Company Overview
         11.2.2. Product Portfolio
         11.2.3. SWOT Analysis
         11.2.4. Financial Overview
         11.2.5. Strategic Overview
   11.3. Hitachi Medical Systems
         11.3.1. Company Overview
         11.3.2. Product Portfolio
         11.3.3. SWOT Analysis
         11.3.4. Financial Overview
         11.3.5. Strategic Overview
   11.4.   Hologic Corporation
         11.4.1. Company Overview
         11.4.2. Product Portfolio
         11.4.3. SWOT Analysis
         11.4.4. Financial Overview
         11.4.5. Strategic Overview
   11.5. Orthoscan Inc.
         11.5.1. Company Overview
         11.5.2. Product Portfolio
         11.5.3. SWOT Analysis
         11.5.4. Financial Overview
         11.5.5. Strategic Overview          
   11.6. Philips Healthcare
         11.6.1. Company Overview
         11.6.2. Product Portfolio
         11.6.3. SWOT Analysis
         11.6.4. Financial Overview
         11.6.5. Strategic Overview      
   11.7. Shimadzu Medical
         11.7.1. Company Overview
         11.7.2. Product Portfolio
         11.7.3. SWOT Analysis
         11.7.4. Financial Overview
         11.7.5. Strategic Overview
   11.8. Siemens Health
         11.8.1. Company Overview
         11.8.2. Product Portfolio
         11.8.3. SWOT Analysis
         11.8.4. Financial Overview
         11.8.5. Strategic Overview
   11.9. Toshiba Medical Systems
         11.9.1. Company Overview
         11.9.2. Product Portfolio
         11.9.3. SWOT Analysis
         11.9.4. Financial Overview
         11.9.5. Strategic Overview
   11.10. Ziehm Imaging
         11.10.1. Company Overview
         11.10.2. Product Portfolio
         11.10.3. SWOT Analysis
         11.10.4. Financial Overview
         11.10.5. Strategic Overview
 
12. Pre and Post COVID-19 Impact
   12.1. Positive influence on the healthcare industry
   12.2. The financial disruption of the manufacturing sector
   12.3. Impact of COVID-19 on emerging companies
   12.4. Significant mandates in the healthcare regulations initiated by administrations
   12.5. The overall economic slowdown of the developing and developed nations

13. FutureWise SME Key Takeaway Points for Client

Tables

Figures